Price to Earning ratio Analysis of Novo Nordisk A/S - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY PE
Period Ending - Dec-23

7.54


Excellent PE
Period Ending - Dec-22
11.49

Excellent PE
Growth
-34.38 %
Trailing Twelve Months PE
Period Ending - Dec-23

7.05


Excellent PE
PE Analysis of Novo Nordisk A/S
P/E Ratio 7.05 of Novo Nordisk A/S shows that stock price is low compared to company earnings and may be undervalued.
PE Ratio of NVO drastically fell by -34.38 % this year.
PE Ratio with value of 17.14 was highest in Year Dec-19 in last Five Years.
PE Ratio of NVO trending down for at least three Years.
Latest PE Ratio with value of 7.54 is lower than Average PE of 13.10 in last five years.
Other PE Related Info of NVO that may interest you.
Novo Nordisk A/S Overview
CodePricePrevious PricePrice ChangeSector
NVO140.37142.5 1.49 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued.    more ..
Price to Earning Formula

PE Related Ratios
PriceToSalesRatioPriceToBookRatioPriceToCashFlowRatio

Tsr Value Index
Good Value
FY - Historical Price to Earning of Novo Nordisk A/S
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PE7.5411.4913.7215.5917.1417.6218.25
Change-34.38 %-16.26 %-12.00 %-9.07 %-2.70 %-3.43 %-2.76 %
You are view first 7 Records. Log in to view all 39 in Premium view
FY Chart of Price to Earning of Novo Nordisk A/S


Note : All Data Generated at the End of Trading Hours (EOD Data)